Biochemical markers of myocardiodystrophy in sports horses for exercise

  • I. A. Maksymovych Lviv National University of Veterinary Medicine and Biotechnologies named after S.Z. Gzhytskyi, Lviv
  • L. H. Slivinskа Lviv National University of Veterinary Medicine and Biotechnologies named after S.Z. Gzhytskyi, Lviv
  • K. Buczek University of Life Sciences, Lublin
  • M. Staniec University of Life Sciences, Lublin
Keywords: cardiac markers, creatine kinase, lactactdehydrogenase, hydroxybutyrate dehydrogenase, metabolic syndrome

Abstract

As a result of diseases of the heart muscle, substances released from damaged cardiomyocytes, in particular creatinе kinase (CК), lactate dehydrogenase (LDH), myoglobin, cardiac-specific troponins T and I (TrT, TrI), which are called biochemical markers of myocardial damage, come into the blood. For the diagnosis of heart muscle damage, the definition of activity of cardiac isoenzymes is used. There are only isolated proven work devoted to the study of clinical and biochemical features of myocardial damage in horses, which prevents them from being widely used for diagnosis. The aim was to characterize the biochemical blood parameters, including activity of CK isoenzymes (CK-MB), and lactate dehydrogenase (α-Hydroxybutyrate dehydrogenase; HBDH) in sport horses for exercise. 50 horses were included into our research, used in the classic equestrian sport of Ukrainian warmblood horses (n=20), Hanoverian (n=15) and Westphalian (n=15) breeds horses. For all horses, a general analysis and biochemical blood indices were analyzed, characterizing the functional state of the organs (heart, liver, kidneys). Studies were carried out immediately before physical activities and immediately afterwards. The duration of medium intensity of regular training was 1 hour: walk – 5 minutes; rising trot – 10 minutes; walk – 5 minutes; sitting trot – 10 min; walk – 10 minutes; gallop with transition to a walk – 10 min; walk – 10 min. The metabolic reaction that occurs in sports horses during exercise is characterized by dehydration (hyperproteinemia), uremic syndrome (increased urea and creatinine concentrations), electrolyte imbalance (a decrease in sodium and potassium content). The main pathogenesis of myocardial dystrophy in sports horses is the discrepancy between costs and energy recovery in the functioning structures of the heart muscle due to excessive cardiac load and significant increase in energy expenditure, as well as a disturbance in the balance of the electrolytes. After physical activity in the blood serum of sports horses, the activity of AST and LDH increases, and a tendency to increase the activity of CK increases. A specific marker of myocardial damage in sports horses has been detected by CK-MB, since its activity is likely to increase in all experimental animal groups. A less specific marker of myocardial dystrophy in sports horses was the activity of HBDH, since the probable difference was only observed in the horses of the Westphalian breed. Investigation of the activity of AST, CK and CK-MB in horses can serve in the differential diagnosis of rhabdomyolysis syndrome and damage to the cells of the cardiac muscle, in particular for myocardial dystrophy. The obtained results can be used for diagnostics of heart diseases and serve in the future to study the pathogenesis of myocardial diseases in horses.

Downloads

Download data is not yet available.

References

Antman, E., Bassand, J.-P., Klein, W., Ohman, M., Lopez Sendon, J. L., Rydén, L., … Tendera, M. (2000). Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology, 36(3), 959–969.

Allan S. Jaffe, Jan Ravkilde, Robert Roberts, Ulf Naslund, Fred S. Apple, Marcello Galvani & Hugo Katus. (2000). It’s time for a change to a troponin standard. Circulation, 102 (11), 1216–1220.

Amosova, E. N. (2000). Metabolicheskaja terapija povrezhdenija miokarda, obuslovlennogo ishemiej: novyj podhod k lecheniju ishemicheskoj bolezni serdca i serdechnoj nedostatochnosti. Ukrainian Cardiology Journal, 4, 85–92. (in Ukrainian).

Begg, L., Hoffmann, K., & Begg, A. (2006). Serum and plasma cardiac troponin I concentrations in clinically normal Thoroughbreds in training in Australia. Australian Veterinary Journal, 84 (9), 336–337.

Bergero, D., Assenza, A., & Caola, G. (2005). Contribution to our knowledge of the physiology and metabolism of endurance horses. Livestock Production Science, 92(2), 167–176.

Böhm, M., Voors, A. A., Ketelslegers, J.-M., Schirmer, S. H., Turgonyi, E., Bramlage, P., & Zannad, F. (2011). Biomarkers: optimizing treatment guidance in heart failure. Clinical Research in Cardiology, 100(11), 973–981.

Buergelt, C. D., & Buergelt, C. D. (2003). Equine cardiovascular pathology: an overview. Animal Health Research Reviews, 4(2), 109–129.

Cavallini, C., Rugolotto, M. & Savonitto, S. (2005). Prognostic significance of creatine kinase release after percutaneous coronary intervention. Italian Heart Journal, 6 (6), 522–529.

Charnaja, M.A., Dement'eva, I.I., Morozov, Ju.A. & Gladysheva, V.G. (2010). Kardiospecifichnye biomarkery v kardiologii i kardiohirurgii. Chast' 1. Obshhaja harakteristika biomarkerov. Kardiologija i serdechno-sosudistaja hirurgija, 3, 26–33. (in Russian).

Christenson, R.H., Apple, F.S., Morgan, D.L., Alonsozana, G.L., Mascotti, K., Olson, M., Mccormack, R.T., Wians, F.H., Keffer, J.H. & Duh S.H. (1998). Cardiac troponin I measurement with the ACCESS (R) immunoassay system: analytical and clinical performance characteristics. Clinical Chemistry, 44, 52–60.

Dimopoulos, K., Diller, G.-P., Giannakoulas, G., Petraco, R., Chamaidi, A., Karaoli, E., … Gatzoulis, M. A. (2009). Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome. Journal of the American College of Cardiology, 54(22), 2093–2100.

Evans, G. O. (1991). Biochemical assessment of cardiac function and damage in animal species A Review of the Current Approach of the Academic, Governmental and Industrial Institutions Represented by the Animal Clinical Chemistry Association. Journal of Applied Toxicology, 11(1), 15–21.

Gondim, F. J., Zoppi, C. C., dos Reis Silveira, L., Pereira-da-Silva, L., & Vaz de Macedo, D. (2009). Possible Relationship Between Performance and Oxidative Stress in Endurance Horses. Journal of Equine Veterinary Science, 29(4), 206–212.

Greco, D.S., Biller, B. & Van Liew, C.H. (2003). Measurement of plasma atrial peptide as an indicator of prognosis in dogs with cardiac disease. Canadian Veterinary Journal, 44, 293–297.

Harris, P.A. (1998). Equine rhabdomyolysis syndrome. In: Metabolic and Endocrine Problems of the Horse, Ed: T. Watson, W.B. Saunders Co., Philadelphia. 75–90.

Harris, P. A., Marlin, D. J., & Gray, J. (1998). Plasma aspartate aminotransferase and creatine kinaseactivities in thoroughbred racehorses in relation to age, sex, exercise and training. The Veterinary Journal, 155(3), 295–304.

Holt, D. W. (1998). Pre-Clinical Application of Markers of Myocardial Damage. Myocardial Damage, 201–211.

Ibáñez, J., Sobrado, R., Rivero, M., Olite, J., Idoate, I., Berrozpe, I., Arina, E., Metola, L., & Sesma, J. (2009). Utilidad de la troponina-I, CPK-MB y mioglobina en el diagnóstico del infarto de miocardio y de los procesos de necrosis muscular de origen no cardiaco. Anales del Sistema Sanitario de Navarra, 24(1), 15-23.

Kratz, A., Lewandrowski, K. B., Siegel, A. J., Chun, K. Y., Flood, J. G., Van Cott, E. M., & Lee-Lewandrowski, E. (2002). Effect of Marathon Running on Hematologic and Biochemical Laboratory Parameters, Including Cardiac Markers. American Journal of Clinical Pathology, 118(6), 856–863.

Leont'eva, I.V. Suhorukov, V.S. & Kljuchnikov, S.O. (2004). Mitohondrial'naja disfunkcija pri kardiomiopatijah u detej. Lekcii po pediatrii. 4. Kardiologija. Moskva. (in Russian).

Lishnevskaja, V. Ju. (2008). Metabolicheskaja terapija pri IBS – iz proshlogo v budushhee. Consilium Medicum Ukraina, 1, 34–39. (in Russian).

Löfberg, M. (1995). Myosin Heavy-Chain Fragments and Cardiac Troponins in the Serum in Rhabdomyolysis. Archives of Neurology, 52(12), 1210.

Lyzlova, S. N. & Stefanova, V. E. (1994). Kreatinkinaza kak pokazatel' funkcional'nogo sostojanija organizma. Fiziologicheskij zhurnal im. I.M. Sechenova, 80 (9), 155–162. (in Russian).

Maksymovych, I. (2017). Exchange of electrolytes in sports horse for exercise. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies, 19(77), 100-104.

Maksymovych, I. A., & Slivinskа, L. G. (2017). Metabolic syndrome of horses during physical activity (diagnostics criteria). The Animal Biology, 19(4), 36–42.

Maksymovych, I., & Slivinska, L. (2015). Diagnostic value of blood biomarkers for heart disease in horses. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies, 17(1), 100-106.

Paleev, N.R. & Levina L.I. (1991). Nekoronarogennye zabolevanija serdca: miokardity, kardiomiopatii, distrofii miokarda. Diagnostika i lechenie vnutrennih boleznej: rukovodstvo. Ed. F.I. Komarova. Medicine. Moscow (in Russian).

Phillips, W., Giguere, S., Franklin, R.P., Hernandez, J., Adin, D., Peloso, J.G. (2003). Cardiac troponin I in pastured and racetraining thoroughbred horses. Journal Veterinary Internal Medicine, 17, 597–599.

Räsänen, L. A., Wiitanen, P. A. S., Lilius, E.-M., Hyyppä, S., & Pösö, A. R. (1996). Accumulation of uric acid in plasma after repeated bouts of exercise in the horse. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 114(2), 139–144.

Sangadzhieva, V. Sh. (2008). Kliniko-biohimicheskie osobennosti serdechnoj dejatel'nosti u detej doshkol'nogo vozrasta, chasto bolejushhih respiratornymi zabolevanijami. Extended abstract of candidates thesis. Astrahan' (in Russian).

Santos, E. S. dos, Pereira, M. P., Minuzzo, L., Moreira, D. A. R., Ramos, R., Avezum, Á., … Piegas, L. S. (2006). Cardioversão elétrica e lesão miocárdica: avaliação pelos novos marcadores de injúria cardíaca. Arquivos Brasileiros de Cardiologia, 86(3).

Singh, T.P., Nigam, A.K., Gupta, A.K. & Singh, B. (2011). Cardiac Biomarkers: When to Test? Physician Perspective. JIACM, 12 (2), 117–121.

Sribhen, C., Sitthichaiyakul, A., Kongpiromchean, Y., Sribhen, K. (2007). Influence of Training Exercise on Clinical Plasma Chemistry Parameters and Cardiac Markers in Race Horses. Kasetsart Journal (Nat. Sci.), 41, 478–483.

Tarmonova, L.Ju. & Shutov, A.M. (2007). Anemija i disfunkcija pochek u bol'nyh pozhilogo i starcheskogo vozrasta s diastolicheskoj serdechnoj nedostatochnost'ju. Klinicheskaja gerontologija, 13 (11), 8–12. (in Russian).

Valberg, S., Jonsson, L., Lindholm, A., & Holmgren, N. (1993). Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Veterinary Journal, 25(1), 11–16.

Van Der Vekens, N., Decloedt, A., De Clercq, D., Verheyen, T., Van Loon, G. (2012). The use of cardiac biomarkers in veterinary medicine: the equine perspective. Vlaams Diergeneeskundig Tijdschrift, 81, 319–327.

Wanderley, E. K., da Silva Cavalcante Bem, B., Melo, S. K. M., Gonzalez, J. C., Cordeiro Manso, H. E. C. C., & Manso Filho, H. C. (2015). Hematological and Biochemical Changes in Mangalarga Marchador Horses After a Four-Beat Gait Challenge in Three Different Distances. Journal of Equine Veterinary Science, 35(4), 259–263.

Zaninotto, M., Altinier, S., Lachin, M., Carraro, P., Plebani, M. (1996). Fluoroenzymometric method to measure cardiac troponin I in serum of patients with myocardial infarction. Clinical Chemistry, 42 (9), 1460–1466.


Abstract views: 127
PDF Downloads: 94
How to Cite
Maksymovych, I., SlivinskаL., Buczek, K., & Staniec, M. (1). Biochemical markers of myocardiodystrophy in sports horses for exercise. Theoretical and Applied Veterinary Medicine, 5(4), 37-44. Retrieved from https://bulletin-biosafety.com/index.php/journal/article/view/161